The AIDS dementia complex: clinical and basic neuroscience with implications for novel molecular therapies - PubMed

Review

The AIDS dementia complex: clinical and basic neuroscience with implications for novel molecular therapies

B A Navia et al. Neurotox Res. 2005 Oct.

Abstract

The AIDS dementia complex (ADC, also referred to as HIV-associated cognitive impairment) is a common disorder among HIV-infected patients associated with both inflammatory and neurodegenerative processes. This review describes recent advances in the clinical and basic neurosciences of HIV infection and discusses the multivariable nature of what has become a chronic disorder in the context of highly active antiretroviral therapies (HAART). Since its initial description twenty years ago, advances in cell and molecular biology along with those in neuroimaging have furthered our understanding of the underlying pathogenic mechanisms. The clinical and neuropsychological profile of ADC is generally consistent with a "frontal-subcortical" pattern of injury. Neuropathogenesis is largely driven by indirect mechanisms mediated by infected, or more commonly, immune activated macrophages, which secrete viral and host-derived factors. Magnetic resonance spectroscopy (MRS) provides a robust in vivo method to measure the inflammatory and neurotoxic events triggered by these factors and their associated signals. Although the use of combined or highly active antiretroviral therapies (HAART) has significantly improved survival rates, cerebral injury and cognitive impairment remain common events. Factors such as aging and chronic infection will likely impact the course of this disease, its pathogenesis, and treatment. The combined observations presented in this review suggest a number of critical areas for future inquiry.

Similar articles

• Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.

  Cohen RA, Harezlak J, Schifitto G, Hana G, Clark U, Gongvatana A, Paul R, Taylor M, Thompson P, Alger J, Brown M, Zhong J, Campbell T, Singer E, Daar E, McMahon D, Tso Y, Yiannoutsos CT, Navia B. Cohen RA, et al. J Neurovirol. 2010 Feb;16(1):25-32. doi: 10.3109/13550280903552420. J Neurovirol. 2010. PMID: 20113183 Free PMC article.

• Neuroprotective strategies for HIV-1 associated dementia.

  Dou H, Kingsley JD, Mosley RL, Gelbard HA, Gendelman HE. Dou H, et al. Neurotox Res. 2004;6(7-8):503-21. doi: 10.1007/BF03033447. Neurotox Res. 2004. PMID: 15639783 Review.

• HIV-associated dementia in the era of highly active antiretroviral therapy (HAART).

  Xia C, Luo D, Yu X, Jiang S, Liu S. Xia C, et al. Microbes Infect. 2011 May;13(5):419-25. doi: 10.1016/j.micinf.2011.01.004. Epub 2011 Jan 22. Microbes Infect. 2011. PMID: 21262373 Review.

• Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies.

  Tate DF, Sampat M, Harezlak J, Fiecas M, Hogan J, Dewey J, McCaffrey D, Branson D, Russell T, Conley J, Taylor M, Schifitto G, Zhong J, Daar ES, Alger J, Brown M, Singer E, Campbell T, McMahon D, Tso Y, Matesan J, Letendre S, Paulose S, Gaugh M, Tripoli C, Yiannoutsos C, Bigler ED, Cohen RA, Guttmann CR, Navia B; HIV Neuroimaging Consortium. Tate DF, et al. J Neurovirol. 2011 Aug;17(4):368-79. doi: 10.1007/s13365-011-0033-6. Epub 2011 May 10. J Neurovirol. 2011. PMID: 21556960 Free PMC article.

• HAART & the molecular biology of AIDS dementia complex.

  Saksena NK, Smit TK. Saksena NK, et al. Indian J Med Res. 2005 Apr;121(4):256-69. Indian J Med Res. 2005. PMID: 15817943 Review.

Cited by

• HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions.

  Persidsky Y, Ho W, Ramirez SH, Potula R, Abood ME, Unterwald E, Tuma R. Persidsky Y, et al. Brain Behav Immun. 2011 Jun;25 Suppl 1(Suppl 1):S61-70. doi: 10.1016/j.bbi.2011.03.001. Epub 2011 Mar 21. Brain Behav Immun. 2011. PMID: 21397004 Free PMC article. Review.

• Disrupted cerebral metabolite levels and lower nadir CD4 + counts are linked to brain volume deficits in 210 HIV-infected patients on stable treatment.

  Hua X, Boyle CP, Harezlak J, Tate DF, Yiannoutsos CT, Cohen R, Schifitto G, Gongvatana A, Zhong J, Zhu T, Taylor MJ, Campbell TB, Daar ES, Alger JR, Singer E, Buchthal S, Toga AW, Navia B, Thompson PM; HIV Neuroimaging Consortium. Hua X, et al. Neuroimage Clin. 2013 Aug 3;3:132-42. doi: 10.1016/j.nicl.2013.07.009. eCollection 2013. Neuroimage Clin. 2013. PMID: 24179857 Free PMC article.

• Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV.

  Paul RH, Ernst T, Brickman AM, Yiannoutsos CT, Tate DF, Cohen RA, Navia BA; ACTG 301 team; ACTG 700 team; HIV MRS Consortium. Paul RH, et al. J Int Neuropsychol Soc. 2008 Sep;14(5):725-33. doi: 10.1017/S1355617708080910. J Int Neuropsychol Soc. 2008. PMID: 18764968 Free PMC article.

• Alcohol Use and Abuse Conspires With HIV Infection to Aggravate Intestinal Dysbiosis and Increase Microbial Translocation in People Living With HIV: A Review.

  Yan J, Ouyang J, Isnard S, Zhou X, Harypursat V, Routy JP, Chen Y. Yan J, et al. Front Immunol. 2021 Dec 17;12:741658. doi: 10.3389/fimmu.2021.741658. eCollection 2021. Front Immunol. 2021. PMID: 34975838 Free PMC article. Review.

• Senile Dementia from Neuroscientific and Islamic Perspectives.

  Tumiran MA, Abdul Rahman NN, Mohd Saat R, Ismail AZ, Ruzali WAW, Bashar NKN, Hasan Adli DS. Tumiran MA, et al. J Relig Health. 2018 Feb;57(1):1-11. doi: 10.1007/s10943-015-0079-5. J Relig Health. 2018. PMID: 26160145

References

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer